Premier Pharmacy Labs Inc is recalling 40,220 units of various injectable and ophthalmic drugs, including Sodium Bicarbonate, Succinylcholine Chloride, and Neostigmine Methylsulfate, because they may not be sterile. An FDA inspection revealed that the manufacturing facility had insufficient environmental controls and potential cross-contamination issues, which means the medications could be contaminated with bacteria or other pathogens. These products were distributed nationwide in the USA to hospitals and clinics. If you have been treated with any of these medications, you should contact your healthcare provider or pharmacist immediately, as the firm has initiated this voluntary recall to prevent potential infections.
The lack of assurance of sterility means these injectable and eye medications could contain microbial contamination; if a non-sterile drug is injected or placed in the eye, it can lead to serious, life-threatening infections or permanent vision loss.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.